Navigation Links
QBI's PreserveX product passes initial test

Madison, Wis. - Ralph Kauten is taking direct aim at three unfavorable metrics, and one of his newest weapons just passed an early test.

Kauten, CEO of QBI Life Sciences, recently received good news from an initial screening of its PreserveX Polymeric Micelles, a core product. The screening, which employed UGT1A1, an enzyme that metabo......

Full article >>> es that give researchers every reason to believe they may have discovered an effective new drug.

The time consuming and costly nature of drug discovery is one reason that pharmaceutical companies are not working to develop drugs for rare diseases - the cost is higher, and the size of the population that benefits is smaller, making it less likely that "pharma" will recoup its investment.
Full article >>> Kauten said.

Evasive capital?

QBI is a division of Quintessence Biosciences, Inc., which is seeking between $5 million and $10 million in private funding to test its Evade technology in human clinical trials. The technology, developed by UW researchers from a protein that plays a role in digesting food, has been modified to produce a d......

Full article >>>
'"/> By Joe Vanden Plas 06/07/06

Related biology technology :

1. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
2. Advantages of Roche Applied Science amplification products
3. Find the optimal product for your PCR application
4. Trouble-shooting: No product
5. Find the optimal product for your application
6. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
7. Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS
8. Using THERMAL DESORPTION GAS CHROMATOGRAPHY for the identification of fragrance and other components in cosmetic products
9. WARF enters licensing agreements for stem cell products
10. Surgical products company wins Governors Business Plan Contest
11. Merge unveils next-generation imaging-informatics product
Post Your Comments:

(Date:10/13/2015)... 2015 PharmaCyte Biotech, Inc. (OTCQB: PMCB) shares closed ... at near average with 1,308,352 shares being traded. PMCB shares ... hitting a low of $.072 in September, then bouncing back ... Our due diligence will show investors in PharmaCyte Biotech, ... report by using the link below at no cost. ...
(Date:10/13/2015)... , October 13, 2015 " Microbiology ... Forecast 2015 - 2023 " , the global ... is anticipated to reach US$7.59 bn by 2023, expanding at a ... --> " Microbiology Culture Market - Global Industry ... " , the global microbiology culture market was valued ...
(Date:10/13/2015)... TapImmune, Inc. (TPIV), a ... peptide and gene-based immunotherapeutics and vaccines for the treatment ... presenting company at the Dawson James Small Cap ... Jupiter, Florida on October 15, ... clinical-stage immunotherapy company specializing in the development of innovative ...
(Date:10/13/2015)... Charlotte, NC (PRWEB) , ... October 13, 2015 ... ... high intensity focused ultrasound (HIFU) technologies, announced today that it received de novo ... 450 in the U.S. for the ablation of prostate tissue. Sonablate® is ...
Breaking Biology Technology:
(Date:10/8/2015)... Calif. , Oct. 8, 2015 ... of human interface solutions, announced today that it ... of fiscal 2016 on Thursday, October 22, 2015, ... host a corresponding conference call for analysts and ... during which management may discuss forward-looking information.    ...
(Date:10/7/2015)... Sweden , October 8, 2015 ... the revenues for Fingerprint Cards (FPC) during third quarter 2015 ... revenue guidance of around 860 MSEK that was communicated 20 ... Considering a further strengthened delivery capacity and a continued growing ... quarter 2015 is estimated to be higher than during the ...
(Date:10/6/2015)... , Oct. 6, 2015  Maverix Biomics, Inc., ... enhancements to its software portfolio with the debut ... for differential expression in eukaryotes. The software is ... a cloud-based genomic analysis solution that leverages proven ... from next-generation sequencing efforts. Garry Nolan,s ...
Breaking Biology News(10 mins):